Medicine overpricing in India has triggered a dispute as drug companies challenge the NPPA’s proposal to shift sole accountability onto manufacturers.
The global race to outpace cancer is accelerating, with MedGenome, HUTCHMED, AbbVie and Cipla advancing detection, treatment, survival and access.
VitSupp, a science-first wellness brand that aims to simplify nutrition, has announced the launch of its first product: a clean-label, high-absorption Vegan Vitamin D3 + K2 supplement, specifically created
India could face 16.9 million dementia cases by 2036, making a stronger dementia care ecosystem an urgent priority now.
As swine flu cases climb, Uttar Pradesh moves to make government hospital testing free and strengthens surveillance across the state.
Pharma companies are advancing critical care with innovative drugs, rare-disease research, and preventive diagnostics to address unmet needs.
Swine flu concerns are spreading from Delhi to Agra as Uttar Pradesh steps up surveillance, screening and hospital preparedness to track H1N1 cases.
The Novartis MS Pill, Rhapsido (remibrutinib), has cleared a major Phase 3 hurdle in relapsing multiple sclerosis (RMS). But the headline comes with an important clinical caveat. The Novartis MS pill significantly reduced annualized...
India's cancer challenge is growing, while breakthrough therapies today offer new hope for patients through earlier detection and innovation.
GSK is pushing its flu vaccine candidate into a crucial late-stage trial. The company plans to start a Phase III trial in September 2026. The move follows positive Phase II results for its mRNA flu vaccine candidate. The vaccine produced stronger...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")